Medical Effectiveness and High-cost Drugs
Led by Anar Dossa who brings a wealth of expertise in drug cost management, and Jenni Noble, who brings her extensive experience of provider network management and end-to-end care strategy, this network tackles the evolving landscape of healthcare provision and costs, and the role of health insurance executives in shaping a sustainable way forward towards accessible, equitable and affordable healthcare. Topics such as care settings, effective deployment of digital technology, health technology assessment, personalised therapies, high-cost drugs, outcomes, reimbursement models, benchmarking around drug pricing, hospital stay duration, etc. all make this one of the core networks at iFHP. Network members include CEOs, CMOs, Heads of Provider Networks, Directors of Pharmacy, Heads of Strategy amongst others.